Concepedia

Calvin J. Gordon

CJ

Statistics

Publications

10

Citations

2.8K

H-Index

10

Active since

2020

Affiliations

University of Alberta(Current)

Gilead Sciences (United States)

Calvin J. Gordon is an author at University of Alberta specializing in molecular biology, virology, and molecular virology.

ORCID

Publications per year

2020–2024

10

Publications

10

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

Calvin J. Gordon, Egor P. Tchesnokov, Emma Woolner et al. · Journal of Biological Chemistry · 2020 · 1K citations · Full text

, , +16

The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus

Calvin J. Gordon, Egor P. Tchesnokov, Joy Y. Feng et al. · Journal of Biological Chemistry · 2020 · 890 citations · Full text

, , +17

Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template

Calvin J. Gordon, Egor P. Tchesnokov, Raymond F. Schinazi et al. · Journal of Biological Chemistry · 2021 · 298 citations · Full text

, , +16

Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

Laura J. Stevens, Andrea J. Pruijssers, Hery W. Lee et al. · Science Translational Medicine · 2022 · 252 citations · Full text

, , +17

Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action

Egor P. Tchesnokov, Calvin J. Gordon, Emma Woolner et al. · Journal of Biological Chemistry · 2020 · 167 citations · Full text

, , +17

1–5 of 10